212 related articles for article (PubMed ID: 22370168)
1. Characterisation of inflammatory infiltrates in lesions of the oral mucosa, skin, and bronchioles in a case of paraneoplastic pemphigus.
Iida K; Yamaguchi F; Hibi K; Tate G; Ohyama B; Numata S; Hashimoto T; Sato M; Uchida T; Sueki H
Eur J Dermatol; 2012; 22(1):154-5. PubMed ID: 22370168
[No Abstract] [Full Text] [Related]
2. The mechanism of respiratory failure in paraneoplastic pemphigus.
Nousari HC; Deterding R; Wojtczack H; Aho S; Uitto J; Hashimoto T; Anhalt GJ
N Engl J Med; 1999 May; 340(18):1406-10. PubMed ID: 10228191
[No Abstract] [Full Text] [Related]
3. Paraneoplastic pemphigus.
Zhu X; Zhang B
J Dermatol; 2007 Aug; 34(8):503-11. PubMed ID: 17683379
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic pemphigus in association with Castleman disease of the pararenal retroperitoneum.
Wen X; Jiang X
J Dermatol; 2012 Jul; 39(7):662-4. PubMed ID: 22221261
[No Abstract] [Full Text] [Related]
5. Paraneoplastic pemphigus presenting as erythrodermic lichenoid dermatitis with concomitant features of pemphigus foliaceus.
Fukumoto T; Shiroyama Y; Niizeki H; Kobayashi N; Asada H; Ishii N; Hashimoto T; Miyagawa S
J Dermatol; 2007 Sep; 34(9):645-9. PubMed ID: 17727368
[TBL] [Abstract][Full Text] [Related]
6. Epitopes in the linker subdomain region of envoplakin recognized by autoantibodies in paraneoplastic pemphigus patients.
Zhang B; Zheng R; Wang J; Bu D; Zhu X
J Invest Dermatol; 2006 Apr; 126(4):832-40. PubMed ID: 16470171
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic pemphigus with Castleman's disease and bronchiolitis obliterans.
Jindal T; Meena M; Kumar A; Khaitan BK
Pediatr Int; 2011 Dec; 53(6):1108-9. PubMed ID: 22181577
[No Abstract] [Full Text] [Related]
8. A case of paraneoplastic pemphigus associated with Castleman disease reacting with multiple autoantigens, including the p200 protein.
Oh SJ; Lee SE; Hashimoto T; Kim SC
Br J Dermatol; 2016 Apr; 174(4):930-2. PubMed ID: 27115591
[No Abstract] [Full Text] [Related]
9. Fatal paraneoplastic pemphigus after removal of Castleman's disease in a child.
Daneshpazhooh M; Moeineddin F; Kiani A; Naraghi ZS; Firooz A; Akhyani M; Chams-Davatchi C
Pediatr Dermatol; 2012; 29(5):656-7. PubMed ID: 22276661
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic pemphigus in association with Castleman's disease.
Nikolskaia OV; Nousari CH; Anhalt GJ
Br J Dermatol; 2003 Dec; 149(6):1143-51. PubMed ID: 14674890
[TBL] [Abstract][Full Text] [Related]
11. Castleman's tumours and production of autoantibody in paraneoplastic pemphigus.
Wang L; Bu D; Yang Y; Chen X; Zhu X
Lancet; 2004 Feb; 363(9408):525-31. PubMed ID: 14975615
[TBL] [Abstract][Full Text] [Related]
12. Paraneoplastic pemphigus associated with Castleman tumor: a commonly reported subtype of paraneoplastic pemphigus in China.
Wang J; Zhu X; Li R; Tu P; Wang R; Zhang L; Li T; Chen X; Wang A; Yang S; Wu Y; Yang H; Ji S
Arch Dermatol; 2005 Oct; 141(10):1285-93. PubMed ID: 16230567
[TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis of 12 Korean patients with paraneoplastic pemphigus.
Choi Y; Nam KH; Lee JB; Lee JY; Ihm CW; Lee SE; Oh SH; Hashimoto T; Kim SC
J Dermatol; 2012 Dec; 39(12):973-81. PubMed ID: 22938021
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic pemphigus associated with Castleman's disease and asymptomatic bronchiolitis obliterans.
Fujimoto W; Kanehiro A; Kuwamoto-Hara K; Saitoh M; Nakakita T; Amagai M; Arata J; Iwatsuki K
Eur J Dermatol; 2002; 12(4):355-9. PubMed ID: 12095881
[TBL] [Abstract][Full Text] [Related]
15. Role of autoantibodies against the linker subdomains of envoplakin and periplakin in the pathogenesis of paraneoplastic pemphigus.
Li J; Bu DF; Huang YC; Zhu XJ
Chin Med J (Engl); 2009 Mar; 122(5):486-95. PubMed ID: 19323896
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors of paraneoplastic pemphigus.
Leger S; Picard D; Ingen-Housz-Oro S; Arnault JP; Aubin F; Carsuzaa F; Chaumentin G; Chevrant-Breton J; Chosidow O; Crickx B; D'incan M; Dandurand M; Debarbieux S; Delaporte E; Dereure O; Doutre MS; Guillet G; Jullien D; Kupfer I; Lacour JP; Leonard F; Lok C; Machet L; Martin L; Paul C; Pignon JM; Robert C; Thomas L; Weiller PJ; Ferranti V; Gilbert D; Courville P; Houivet E; Benichou J; Joly P
Arch Dermatol; 2012 Oct; 148(10):1165-72. PubMed ID: 22801794
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic pemphigus associated with Waldenström's macroglobulinemia.
Shirai T; Kiniwa Y; Ishii N; Hashimoto T; Senoo Y; Urushihata K; Ashida A; Okuyama R
J Dermatol; 2020 May; 47(5):e200-e201. PubMed ID: 32103535
[No Abstract] [Full Text] [Related]
18. Case of paraneoplastic pemphigus with immunoglobulin (Ig)G and IgA antibodies to various antigens.
Otsuka Y; Ueno T; Yamase A; Ito M; Osada S; Kawana S; Funasaka Y; Teye K; Ishii N; Hashimoto T; Saeki H
J Dermatol; 2016 Aug; 43(8):944-6. PubMed ID: 26969813
[TBL] [Abstract][Full Text] [Related]
19. Distinguishing paraneoplastic pemphigus with keratotic skin lesions lacking anti-plakin antibodies from severe lichen planus.
Shimokata-Isoe M; Hashimoto T; Hirose M; Shinada Y; Matsuo S; Munetsugu T; Koga H; Ishii N; Satoh T
Eur J Dermatol; 2021 Apr; 31(2):273-275. PubMed ID: 33871365
[No Abstract] [Full Text] [Related]
20. Decline of disease activity and autoantibodies to desmoglein 3 and envoplakin by oral prednisolone in paraneoplastic pemphigus with benign thymoma.
Ishii N; Hamada T; Koga H; Sogame R; Ohyama B; Fukuda S; Natsuaki Y; Dainichi T; Karashima T; Nakama T; Tsuruta D; Hashimoto T
Eur J Dermatol; 2012; 22(4):547-9. PubMed ID: 22548836
[No Abstract] [Full Text] [Related]
[Next] [New Search]
